Pharmacielo Ltd (V:PCLO) — Market Cap & Net Worth
Market Cap & Net Worth: Pharmacielo Ltd (PCLO)
Pharmacielo Ltd (V:PCLO) has a market capitalization of $8.16 Million (CA$11.28 Million) as of May 2, 2026. Listed on the V stock exchange, this Canada-based company holds position #27343 globally and #1184 in its home market, demonstrating a 33.33% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmacielo Ltd's stock price CA$0.06 by its total outstanding shares 187983694 (187.98 Million). Analyse cash flow conversion of Pharmacielo Ltd to see how efficiently the company converts income to cash.
Pharmacielo Ltd Market Cap History: 2018 to 2026
Pharmacielo Ltd's market capitalization history from 2018 to 2026. Data shows change from $28.56 Million to $8.16 Million (-17.73% CAGR).
Pharmacielo Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmacielo Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.13x
Pharmacielo Ltd's market cap is 3.13 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $414.75 Million | $786.90K | -$34.62 Million | 527.07x | N/A |
| 2020 | $282.85 Million | $2.65 Million | -$44.26 Million | 106.58x | N/A |
| 2021 | $142.78 Million | $1.94 Million | -$26.92 Million | 73.41x | N/A |
| 2022 | $23.80 Million | $5.31 Million | -$16.04 Million | 4.48x | N/A |
| 2023 | $24.48 Million | $1.54 Million | -$16.30 Million | 15.88x | N/A |
| 2024 | $10.88 Million | $3.48 Million | -$9.14 Million | 3.13x | N/A |
Competitor Companies of PCLO by Market Capitalization
Companies near Pharmacielo Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Pharmacielo Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Pharmacielo Ltd Historical Marketcap From 2018 to 2026
Between 2018 and today, Pharmacielo Ltd's market cap moved from $28.56 Million to $ 8.16 Million, with a yearly change of -17.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$8.16 Million | +33.33% |
| 2025 | CA$6.12 Million | -43.75% |
| 2024 | CA$10.88 Million | -55.56% |
| 2023 | CA$24.48 Million | +2.86% |
| 2022 | CA$23.80 Million | -83.33% |
| 2021 | CA$142.78 Million | -49.52% |
| 2020 | CA$282.85 Million | -31.80% |
| 2019 | CA$414.75 Million | +1352.38% |
| 2018 | CA$28.56 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Pharmacielo Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.16 Million USD |
| MoneyControl | $8.16 Million USD |
| MarketWatch | $8.16 Million USD |
| marketcap.company | $8.16 Million USD |
| Reuters | $8.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pharmacielo Ltd
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its… Read more